Sangon Biotech

Name

Sangon Biotech

Legal name

生工生物工程(上海)股份有限公司 (Sangon Biotech (Shanghai) Co., Ltd.)

Website

https://sangon.com

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

1,001–5,000 employees

Ownership category

akta.pro rank

Product category

Life Sciences Reagents and Services

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

mRNA/LNP & Nucleic Acid Therapeutics CDMO (HLAGABAF)

akta.pro secondary industries

mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA) (HLAGAGAC), Gene Therapy (Viral Vector/Plasmid) CDMO (HLAGABAE), GMP Quality, Validation & Regulatory Support (GMP/CSV/Qualification) (HLAGAGAL)

Keywords

• DNA synthesis services
• Biochemical reagents
• Gene synthesis products
• Monoclonal antibody development
• NGS sequencing services

Headquarters

HQ city

Shanghai

HQ country

China

HQ region

Asia

Offices11 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Biochemical Reagents & Consumables Sales: Sale of biochemical reagents including microbial culture media, amino acids, antibiotics, vitamins, buffers, dyes and indicators, enzymes and coenzymes, plant hormones, cleaning agents, molecular biology products, proteins, antibodies, cell biology products, and laboratory consumables and instruments. Sold directly via e-commerce platform, sales team, and distribution channels.
2. DNA & RNA Synthesis Services: Custom DNA synthesis including常规引物合成, qPCR primers and probes, large-scale oligo synthesis, pre-designed ready-made primers, chip synthesis, oligo pool synthesis, circular single-stranded DNA, non-natural functional nucleic acid, long ssDNA. RNA synthesis including siRNA, miRNA, in vitro transcription, sgRNA/pegRNA design and synthesis, circular RNA synthesis.
3. Gene Synthesis Services: Full gene synthesis, gene/mutant library construction, plasmid preparation services, and related services.
4. NGS and Sequencing Services: High-throughput sequencing including targeted capture sequencing, epigenetic sequencing, single-cell sequencing, genome sequencing, transcriptome sequencing, KBSeq full plasmid sequencing, multi-omics sequencing (Olink proteomics, SomaSeq 11k proteomics), and one-generation sequencing services.
5. Peptide and Protein Expression Services: Peptide synthesis, recombinant protein expression in prokaryotic, mammalian, Pichia pastoris, and baculovirus-insect cell systems; protein amino acid sequencing, SPR and BLI detection services.
6. Antibody Development Services: SingleB® monoclonal antibody development, hybridoma monoclonal antibody development, anti-idiotype antibody preparation, phage display technology, recombinant antibody expression, hybridoma gene sequencing, antibody humanization, colloidal gold kit development, ELISA kit development.
7. Third-Party Medical Testing Services: Third-party medical testing through Sangon Health Medical Testing Laboratory established in 2018, serving IVD and clinical diagnostic needs.

Go-to-market motion3 records

Distribution channels5 records

Marketing channels8 records

Core offering

Sangon Biotech manufactures and distributes a comprehensive portfolio of life sciences research reagents, kits, consumables, and laboratory instruments, and provides custom synthesis and analytical services including DNA/RNA synthesis, gene synthesis, protein expression, antibody development, and next-generation and first-generation sequencing. The company operates separate industrial-grade and research-grade DNA synthesis production lines, serving industrial biotech diagnostic manufacturers with upstream raw materials and academic and clinical research customers with research tools.

Product overview

Sangon Biotech is a large-scale comprehensive life science products and services platform, providing full coverage from research/R&D tools and services to industrial production upstream raw materials. The portfolio includes: (1) Core biochemical reagent products spanning molecular biology, protein science, antibodies, cell biology, and lab consumables; (2) DNA/RNA synthesis services for research and industrial applications; (3) Gene synthesis, protein expression, and antibody development services; (4) Comprehensive sequencing solutions including first-generation sequencing, NGS (targeted capture, single-cell, genome, transcriptome), and multi-omics (Olink proteomics); (5) Molecular interaction analysis and cell analysis services; (6) IVD solutions including PCR, NGS, and chemiluminescence immunoassay; (7) A bioinformatics cloud platform; (8) Laboratory equipment. As one of the largest DNA synthesis producers globally, the company operates from a 200,000+ m² production base in Shanghai with subsidiaries in Canada, Singapore, Korea, USA, and a global sales network covering 200+ countries.

Differentiator

Problem solved

Functional benefit

Brands

• Bio Basic: Life sciences research products and services brand
• KleanAB
• NBS Biologicals
• Bionics
• 德泰 (Detai)
• KBSeq
• SomaSeq
• Bioinformatics Cloud Platform

Products and services

• Biochemical Reagents

Quantifiable outcome

• Serves 40,000+ biotech diagnostic companies in China for industrial-end solutions
• +4 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Eight partnerships are on record, tiered flagship, core and minor.

• Thermo Fisher ScientificflagshipStrategic or Co-development Partner · 1 January 2023Sangon Biotech entered into a strategic cooperation agreement with Thermo Fisher Scientific in 2023 and co-established a Genetic Science Demonstration Laboratory. This partnership positions Sangon as a local partner for Thermo Fisher's life science tools business in China.
• Bio BasiccoreChannel Partner/ Reseller/ DistributorBio Basic is listed as a partner brand on Sangon Biotech's website, operating as an affiliated distribution entity within the BBI Life Sciences group ecosystem. Bio Basic focuses on molecular biology reagents and serves international markets.
• KleanABminorChannel Partner/ Reseller/ DistributorKleanAB is listed as a partner brand on Sangon Biotech's partner ecosystem page, operating within the broader group distribution network.
• NBS BiologicalsminorChannel Partner/ Reseller/ DistributorNBS Biologicals is listed as a partner brand on Sangon Biotech's website, serving as a UK-based distribution entity for life science reagents.
• Bionics (Korea)minorChannel Partner/ Reseller/ DistributorBionics is a Korean subsidiary/partner of Sangon Biotech, listed as a partner brand on the corporate website and serving the Korean market.
• CasMart (喀斯玛商城)minorChannel Partner/ Reseller/ DistributorSangon Biotech is listed as an approved supplier on the CasMart procurement platform, enabling university and research institution customers to purchase Sangon products through the platform.
• CAAS Procurement Platform (科研物资采购平台)minorChannel Partner/ Reseller/ DistributorSangon Biotech is listed as an approved supplier on the China Academy of Agricultural Sciences (CAAS) procurement platform, facilitating sales to agricultural research institutions.
• BCG (Boston Consulting Group)coreOthersSangon Biotech engaged BCG, a global management consulting firm, in 2023 to support its global strategic planning and international expansion strategy, signaling a structured strategic transformation initiative.

Scale indicators17 records

Recent moves11 records

Expansion highlights6 records

Broad incumbents

• Eurofins Genomics: Part of the global Eurofins Scientific network, offering DNA/RNA synthesis, gene synthesis, oligonucleotides, and genomics services. Broader portfolio but overlaps directly with Sangon's nucleic acid and sequencing services for the global research market.
• Thermo Fisher Scientific: Global life sciences tools giant whose genomics (including GeneArt gene synthesis, oligonucleotide synthesis) and biosciences businesses overlap with Sangon's offerings. Also a strategic partner to Sangon, creating both cooperation and competitive tension.
• WuXi AppTec: China-headquartered global CRO/CDMO giant offering biologics and nucleic acid-related services; an indirect peer through overlapping capabilities in nucleic acid synthesis, gene therapy, and IVD support.

Direct peers

• Twist Bioscience: US-based DNA synthesis company pioneering silicon-chip DNA synthesis at industrial scale, serving gene synthesis, NGS target enrichment, and antibody discovery — directly competitive with Sangon's industrial-grade DNA synthesis and gene synthesis offerings.
• GenScript Biotech: Hong Kong-listed life-sciences tools and services company offering gene synthesis, peptide synthesis, protein expression, antibody development, and cell therapy services — directly overlapping Sangon's core gene synthesis, peptide/protein, and antibody service portfolios. Both serve the global biotech research market with similar technology stacks.
• Integrated DNA Technologies (IDT, Danaher): World-leading oligonucleotide/DNA/RNA synthesis manufacturer owned by Danaher; Sangon's primary global competitor in custom oligo synthesis, qPCR probes, and NGS oligos. Comparable product portfolio and customer base (academic, IVD, biopharma).
• BGI Group: China's leading genomics and life sciences company with synthetic biology, sequencing, and IVD/reagent businesses that directly overlap with Sangon's industrial DNA synthesis and NGS service offerings in the Chinese market.
• Bio Basic: Canadian life-sciences research products and services company — a wholly-owned Sangon subsidiary (BIO BASIC CANADA INC.) and direct peer for international distribution of molecular biology reagents and synthetic biology services.

Others

• Azenta Life Sciences (formerly Brooks Life Sciences): Life sciences sample management and genomic services provider; comparable to Sangon in serving research and industrial customers with consumables and services, though more focused on automation/storage infrastructure.

Emerging players

• Synbio Technologies: China-based synthetic biology company specializing in gene synthesis, DNA/RNA synthesis, and protein engineering services — a direct domestic competitor to Sangon's core nucleic acid and gene synthesis service lines.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/profile.php

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries8 records

Funding overview

Funding rounds2 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sangon Biotech